Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Share Buyback Programme

29 Jan 2025 07:00

RNS Number : 0299V
Crystal Amber Fund Limited
29 January 2025
 

29 January 2025

 

Crystal Amber Fund Limited

("Crystal Amber Fund", the "Company" or the "Fund")

 

Share Buyback Programme

 

Crystal Amber Fund announces that it intends to continue the buyback of Company shares under a share buyback programme for the period to 24 February 2025. Since 15 December 2023, c.£10 million has been returned to shareholders in share buybacks and in order to continue this and reduce the Company's share capital, from now until 24 February 2025 the Company intends to conduct on-market purchases under the share buyback programme to repurchase ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") up to an aggregate amount of £5 million, but no more than 10,167,070 Ordinary Shares, pursuant to the authority obtained at the Company's annual general meeting on 13 December 2024 (the "Buyback").

 

The maximum price which may be paid by the Company per Ordinary Share shall not be more than the higher of:

a.  105 per cent of the average of the middle market quotations for an Ordinary Share as derived from the AIM market of the London Stock Exchange plc for the five business days immediately preceding the day on which the purchase is made; and

b. the value of an Ordinary Share calculated on the basis of the higher of the price quoted for (i) the last independent trade of and (ii) the highest current independent bid for the Ordinary Shares.

 

Due to the relatively low liquidity in the Ordinary Shares, the Company may purchase Ordinary Shares pursuant to the Buyback on any trading day materially in excess of 25 per cent of the average daily volume, being the limit prescribed pursuant to Article 5(1) of the EU Market Abuse Regulation (2014/596/EU) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR") and accordingly, the Company may not benefit from that exemption.

 

There is no guarantee that the Buyback programme will be implemented in full or that any purchases will be made. The Company reserves the right to bring a halt to the Buyback under circumstances that it deems to be appropriate and in accordance with relevant law and regulation.

 

The Company will make further announcements in due course following any share purchases conducted through the Buyback. Ordinary Shares purchased in the Buyback will be cancelled in due course.

 

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

Jeremy Porter/ Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWURRVBUAUUR
Date   Source Headline
20th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
16th May 20255:22 pmRNSTransaction in Own Shares and Total Voting Rights
15th May 20255:30 pmRNSMonthly Net Asset Value
15th May 20255:15 pmRNSTransaction in Own Shares and Total Voting Rights
6th May 202510:37 amRNSHolding(s) in Company
1st May 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20255:30 pmRNSTotal Voting Rights
25th Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20255:15 pmRNSHolding(s) in Company
23rd Apr 20252:00 pmRNSHolding(s) in Company
22nd Apr 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 202511:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20256:00 pmRNSForm 8.3 - De La Rue plc
10th Apr 202511:00 amRNSForm 8.3 - De La Rue plc
9th Apr 20254:41 pmRNSForm 8.3 - De La Rue plc - Replacement
9th Apr 202510:00 amRNSForm 8.3 - De La Rue plc
8th Apr 202511:30 amRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202510:30 amRNSForm 8.3 - De La Rue plc
7th Apr 202512:00 pmRNSForm 8.3 - De La Rue plc
7th Apr 202510:03 amRNSTransaction in Own Shares and Total Voting Rights
4th Apr 20252:27 pmRNSForm 8.3 - De La Rue plc - Replacement
4th Apr 202511:16 amRNSForm 8.3 - De La Rue plc
1st Apr 20258:43 amRNSTotal Voting Rights
31st Mar 20254:34 pmRNSMonthly Net Asset Value
27th Mar 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 202510:03 amRNSShare Buyback Programme
21st Mar 20257:00 amRNSHalf-year Report
14th Mar 20253:30 pmRNSCancellation of treasury shares
6th Mar 202511:58 amRNSForm 8.3 - De La Rue plc
28th Feb 20255:30 pmRNSTotal Voting Rights
24th Feb 20255:00 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Feb 20257:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20254:23 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSUpdate on Morphic Medical Inc.
19th Feb 20255:13 pmRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20255:06 pmRNSDirector/PDMR Shareholding
19th Feb 202510:18 amRNSForm 8.3 - De La Rue plc
18th Feb 20256:00 pmRNSMonthly Net Asset Value
18th Feb 20255:54 pmRNSTransaction in Own Shares and Total Voting Rights
17th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20256:00 pmRNSForm 8.3 - De La Rue plc
10th Feb 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.